EXOR NV (XAMS:EXO)
€ 100 1.7 (1.73%) Market Cap: 21.40 Bil Enterprise Value: 25.29 Bil PE Ratio: 1.32 PB Ratio: 0.56 GF Score: 32/100

Half Year 2024 Exor NV Earnings Call Transcript

Sep 25, 2024 / 11:00AM GMT
Release Date Price: €97.65 (-0.91%)

Key Points

Positve
  • Net asset value increased to EUR38.3 billion at June 30, up from EUR35.4 billion at January 1.
  • Net debt decreased to EUR3.7 billion at June 30, down from EUR4 billion at the beginning of the year.
  • NAV per share increased by 9% in the first half of the year.
  • Total shareholder return has been growing at a compounded annual growth rate of 20% since inception.
  • Strong performance from listed companies like Ferrari (up 25%), Philips (up 12%), and Iveco (up 29%).
Negative
  • NAV per share growth of 9% underperformed compared to the MSCI World Index's 40% increase.
  • Ferrari's share price dip before the half-year end negatively impacted NAV per share.
  • Stellantis and CNH saw declines of 13% and 15% respectively in the first half of the year.
  • Negative performance of listed securities resulted in a EUR280 million loss.
  • Management costs and financial expenses contributed to a negative EUR57 million impact.
Guido de Boer
Exor NV - Chief Financial Officer

Thank you, Melanie, and good afternoon to everyone. And thank you for joining us today for this presentation of Exor's half year results of 2024.

So starting with the main highlights for the half year. Our net asset value increased to EUR38.3 billion at June 30, up from EUR35.4 billion at January 1. And the main driver of this has been the positive performance of our listed companies as we'll see later in the presentation.

Net debt was equal to EUR3.7 billion at June 30, down from EUR4 billion at the beginning of the year. This decrease is due to the cash flows from dividends being concentrated in the first half of the year. And with that, also our loan-to-value improved to 9% at June 30, down from 10% at the beginning of the year driven by a lower net debt as well as obviously the increase in our gross asset value, net of cash and cash equivalents.

And finally, as we previously announced, as of January 1, Exor reports as an investment entity under IFRS 10. And later in the presentation, we'll provide details regarding this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot